Omar Castaneda Puglianini

Clinical experience of CAR T cells for multiple myeloma.

G. Simmons, Toshihisa Satta, Omar Castaneda Puglianini, 2021, Best practice & research. Clinical haematology.

T-Cell-Based Cellular Immunotherapy of Multiple Myeloma: Current Developments

G. Simmons, Omar Castaneda Puglianini, O. C. Castaneda Puglianini, 2022, Cancers.

Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma.

C. Jacobson, M. Shadman, G. Simmons, 2021, Blood advances.

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

J. Pidala, A. Mishra, Jongphil Kim, 2021, Blood advances.

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Christelle M Colin-Leitzinger, B. Sahaf, A. Mishra, 2022, Blood advances.

Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts

Omar Castaneda Puglianini, Nikolaos Papadantonakis, O. C. Castaneda Puglianini, 2020, Therapeutic advances in hematology.